NCT06337981 - Efficacy and Safety of AJU-S56 in Dry Eye Syndrome Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 22, 2021

Primary Completion Date

June 14, 2022

Study Completion Date

November 28, 2022

Conditions

Dry Eye Syndromes

Interventions

DRUG

(AJU-S56 5% and placebo)

(AJU-S56 5%) and placebo(Vehicle), 1drop/1times, 3times in a day

DRUG

AJU-S56 5%

(AJU-S56 5%), 1drop/1times, 6times in a day

DRUG

Placebo(Vehicle)

Placebo(Vehicle), 1drop/1times, 6times in a day

Trial Locations (1)

AJU Pharm Co., Ltd., Seoul